{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T10:38:11Z","timestamp":1778755091392,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T00:00:00Z","timestamp":1693180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T00:00:00Z","timestamp":1693180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-023-02830-y","type":"journal-article","created":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T07:03:31Z","timestamp":1693206211000},"page":"4203-4215","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Factors affecting recurrence and metastasis in conjunctival melanoma"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6344-5662","authenticated-orcid":false,"given":"Feyza","family":"\u00c7al\u0131\u015f Karanfil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5945-5657","authenticated-orcid":false,"given":"Ahmet Kaan","family":"G\u00fcnd\u00fcz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3447-7785","authenticated-orcid":false,"given":"\u00d6m\u00fcr \u00d6zlenen","family":"G\u00fcnd\u00fcz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0475-7612","authenticated-orcid":false,"given":"Funda Seher","family":"\u00d6zalp Ate\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,28]]},"reference":[{"key":"2830_CR1","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.survophthal.2020.09.004","volume":"66","author":"Y Zeng","year":"2021","unstructured":"Zeng Y, Hu C, Shu L, Pan Y, Zhao L, Pu X, Wu F (2021) Clinical treatment options for early-stage and advanced conjunctival melanoma. Surv Ophthalmol 66:461\u2013470. https:\/\/doi.org\/10.1016\/j.survophthal.2020.09.004","journal-title":"Surv Ophthalmol"},{"key":"2830_CR2","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1136\/bjo.2009.157933","volume":"93","author":"E Triay","year":"2009","unstructured":"Triay E, Bergman L, Nilsson B, All-Ericsson C, Seregard S (2009) Time trends in the incidence of conjunctival melanoma in Sweden. Br J Ophthalmol 93:1524\u20131528. https:\/\/doi.org\/10.1136\/bjo.2009.157933","journal-title":"Br J Ophthalmol"},{"key":"2830_CR3","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/s0002-9394(02)02288-2","volume":"135","author":"GP Yu","year":"2003","unstructured":"Yu GP, Hu DN, McCormick S, Finger PT (2003) Conjunctival melanoma: is it increasing in the United States? Am J Ophthalmol 135:800\u2013806. https:\/\/doi.org\/10.1016\/s0002-9394(02)02288-2","journal-title":"Am J Ophthalmol"},{"key":"2830_CR4","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.ophtha.2022.02.029","volume":"129","author":"S Jia","year":"2022","unstructured":"Jia S, Zhu T, Shi H, Zong C, Bao Y, Wen X, Ge S, Ruan J, Xu S, Jia R, Fan X (2022) American Joint Committee on Cancer Tumor Staging System predicts the outcome and metastasis pattern in conjunctival melanoma. Ophthalmology 129:771\u2013780. https:\/\/doi.org\/10.1016\/j.ophtha.2022.02.029","journal-title":"Ophthalmology"},{"key":"2830_CR5","volume-title":"The AJCC TNM cancer staging manual","author":"SBR Coupland","year":"2017","unstructured":"Coupland SBR, Conway M, Damato BE, Esmaeli B, Albert DM (2017) The AJCC TNM cancer staging manual, 8th edn. Conjunctival melanoma. Springer Publishing Company, New York","edition":"8"},{"key":"2830_CR6","doi-asserted-by":"publisher","unstructured":"Jain P, Finger PT, Damato B, Coupland SE, Heimann H, Kenawy N, Brouwer NJ, Marinkovic M, Van Duinen SG, Caujolle JP, Maschi C, Seregard S, Pelayes D, Folgar M, Yousef YA, Krema H, Gallie B, Calle-Vasquez A (2019) Multicenter, international assessment of the Eighth Edition of the American Joint Committee on Cancer Cancer Staging Manual for conjunctival melanoma. JAMA Ophthalmol 137: 905\u201311. https:\/\/doi.org\/10.1001\/jamaophthalmol.2019.1640","DOI":"10.1001\/jamaophthalmol.2019.1640"},{"key":"2830_CR7","doi-asserted-by":"publisher","unstructured":"Shields CL, Yaghy A, Dalvin LA, Vaidya S, Pacheco RR, Perez AL, Lally SE, Shields JA (2020) Conjunctival melanoma: outcomes based on the American joint committee on cancer clinical classification (8th Edition) of 425 patients at a single ocular oncology center. Asia Pac J Ophthalmol (Phila) 10: 146\u201351. https:\/\/doi.org\/10.1097\/apo.0000000000000343","DOI":"10.1097\/apo.0000000000000343"},{"key":"2830_CR8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1167\/iovs.04-0344","volume":"46","author":"GS Missotten","year":"2005","unstructured":"Missotten GS, Keijser S, De Keizer RJ, De Wolff-Rouendaal D (2005) Conjunctival melanoma in the Netherlands: a nationwide study. Invest Opht Vis Sci 46:75\u201382. https:\/\/doi.org\/10.1167\/iovs.04-0344","journal-title":"Invest Opht Vis Sci"},{"key":"2830_CR9","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1001\/archopht.118.11.1497","volume":"118","author":"CL Shields","year":"2000","unstructured":"Shields CL, Shields JA, G\u00fcnd\u00fcz K, Cater J, Mercado GV, Gross N, Lally B (2000) Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients. Arch Ophthalmol 118:1497\u20131507. https:\/\/doi.org\/10.1001\/archopht.118.11.1497","journal-title":"Arch Ophthalmol"},{"key":"2830_CR10","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1177\/1120672120970393","volume":"31","author":"S Vaidya","year":"2021","unstructured":"Vaidya S, Dalvin LA (2021) Conjunctival melanoma: Risk factors for recurrent or new tumor in 540 patients at a single ocular oncology center. Eur J Ophthalmol 31:2675\u20132685. https:\/\/doi.org\/10.1177\/1120672120970393","journal-title":"Eur J Ophthalmol"},{"key":"2830_CR11","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1097\/ico.0000000000002449","volume":"40","author":"LA Dalvin","year":"2021","unstructured":"Dalvin LA, Yaghy A, Vaidya S, Pacheco RR, Perez AL, Lally SE, Shields JA, Shields CL (2021) Conjunctival melanoma: outcomes based on age at presentation in 629 patients at a single ocular oncology center. Cornea 40:554\u2013563. https:\/\/doi.org\/10.1097\/ico.0000000000002449","journal-title":"Cornea"},{"key":"2830_CR12","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.amjoto.2019.05.013","volume":"40","author":"NB Abt","year":"2019","unstructured":"Abt NB, Zhao J, Huang Y, Eghrari AO (2019) Prognostic factors and survival for malignant conjunctival melanoma and squamous cell carcinoma over four decades. Am J Otolaryngol 40:577\u2013582. https:\/\/doi.org\/10.1016\/j.amjoto.2019.05.013","journal-title":"Am J Otolaryngol"},{"key":"2830_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/aos.13100","volume":"94","author":"AC Larsen","year":"2016","unstructured":"Larsen AC (2016) Conjunctival malignant melanoma in Denmark: Epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile. Acta Ophthalmol 94:1\u201327. https:\/\/doi.org\/10.1111\/aos.13100","journal-title":"Acta Ophthalmol"},{"key":"2830_CR14","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ophtha.2010.06.021","volume":"118","author":"CL Shields","year":"2011","unstructured":"Shields CL, Markowitz JS, Belinsky I, Schwartzstein H, George NS, Lally SE, Mashayekhi A, Shields JA (2011) Conjunctival melanoma: outcomes based on tumor origin in 382 consecutive cases. Ophthalmology 118:389\u2013395. https:\/\/doi.org\/10.1016\/j.ophtha.2010.06.021","journal-title":"Ophthalmology"},{"key":"2830_CR15","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jfma.2020.04.032","volume":"120","author":"PY Chen","year":"2021","unstructured":"Chen PY, Liao YL, Chu YC, Tsai YJ (2021) Conjunctival melanoma: A 20-year survey in a comprehensive medical center. J Formos Med Assoc 120:250\u2013255. https:\/\/doi.org\/10.1016\/j.jfma.2020.04.032","journal-title":"J Formos Med Assoc"},{"key":"2830_CR16","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1080\/08820538.2019.1620793","volume":"34","author":"S Kaliki","year":"2019","unstructured":"Kaliki S, Vasanthapuram VH, Mishra DK (2019) Conjunctival melanoma in Asian INDIANS: a study of 42 patients. Semin Ophthalmol 34:182\u2013187. https:\/\/doi.org\/10.1080\/08820538.2019.1620793","journal-title":"Semin Ophthalmol"},{"key":"2830_CR17","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1001\/jamaophthalmol.2018.3488","volume":"136","author":"O Sagiv","year":"2018","unstructured":"Sagiv O, Sudip DT, Kandl TJ, Ford J, Sniegowski MC, Hwu W-J, Esmaeli B (2018) Immunotherapy with programmed cell death 1 inhibitors for 5 patients with conjunctival melanoma. JAMA Ophthalmol 136:1236\u20131241. https:\/\/doi.org\/10.1001\/jamaophthalmol.2018.3488","journal-title":"JAMA Ophthalmol"},{"key":"2830_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s40425-019-0555-7","volume":"7","author":"PT Finger","year":"2019","unstructured":"Finger PT, Pavlick AC (2019) Checkpoint inhibition immunotherapy for advanced local and systemic conjunctival melanoma: a clinical case series. J Immunother Cancer 7:83. https:\/\/doi.org\/10.1186\/s40425-019-0555-7","journal-title":"J Immunother Cancer"},{"key":"2830_CR19","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1136\/bjophthalmol-2017-311082","volume":"102","author":"NJ Brouwer","year":"2018","unstructured":"Brouwer NJ, Marinkovic M, van Duinen SG, Bleeker JC, Jager MJ, Luyten GPM (2018) Treatment of conjunctival melanoma in a Dutch referral centre. Br J Ophthalmol 102:1277\u20131282. https:\/\/doi.org\/10.1136\/bjophthalmol-2017-311082","journal-title":"Br J Ophthalmol"},{"key":"2830_CR20","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.ophtha.2003.11.001","volume":"111","author":"S Tuomaala","year":"2004","unstructured":"Tuomaala S, Kivel\u00e4 T (2004) Metastatic pattern and survival in disseminated conjunctival melanoma: implications for sentinel lymph node biopsy. Ophthalmology 111:816\u2013821. https:\/\/doi.org\/10.1016\/j.ophtha.2003.11.001","journal-title":"Ophthalmology"},{"key":"2830_CR21","first-page":"471","volume":"98","author":"CL Shields","year":"2000","unstructured":"Shields CL (2000) Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients. Trans Am Ophthalmol Soc 98:471\u2013492","journal-title":"Trans Am Ophthalmol Soc"},{"key":"2830_CR22","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/eye.2008.154","volume":"23","author":"B Damato","year":"2009","unstructured":"Damato B, Coupland SE (2009) An audit of conjunctival melanoma treatment in Liverpool. Eye (Lond) 23:801\u2013809. https:\/\/doi.org\/10.1038\/eye.2008.154","journal-title":"Eye (Lond)"},{"key":"2830_CR23","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41433-021-01508-y","volume":"36","author":"RR Pacheco","year":"2022","unstructured":"Pacheco RR, Yaghy A, Dalvin LA,\u00a0Vaidya S, Perez AL, Lally SE, Shields JA, Shields CL (2022) Conjunctival melanoma: outcomes based on tumour origin in 629 patients at a single ocular oncology centre. Eye (Lond) 36:603\u2013611","journal-title":"Eye (Lond)"},{"key":"2830_CR24","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ajo.2020.10.020","volume":"223","author":"T Milman","year":"2021","unstructured":"Milman T, Eiger-Moscovich M, Henry RK, Folberg R, Coupland SE, Grossniklaus HE, Mudhar HS, Eberhart CG, Heegaard S, Auw-H\u00e4drich C, Herwig-Carl MC, L\u00f6ffler KU, Cherepanoff S, Zhang Q, Sharpe JE, See TRO, Shields CL, Eagle RC Jr (2021) Validation of the newly proposed World Health Organization classification system for conjunctival melanocytic intraepithelial lesions: a comparison with the C-MIN and PAM classification schemes. Am J Ophthalmol 223:60\u201374. https:\/\/doi.org\/10.1016\/j.ajo.2020.10.020","journal-title":"Am J Ophthalmol"},{"key":"2830_CR25","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1136\/bjophthalmol-2020-316293","volume":"105","author":"P Jain","year":"2021","unstructured":"Jain P, Finger PT (2021) Conjunctival melanoma treatment outcomes in 288 patients: a multicentre international data-sharing study. Br J Ophthalmol 105:1358\u20131364. https:\/\/doi.org\/10.1136\/bjophthalmol-2020-316293","journal-title":"Br J Ophthalmol"},{"key":"2830_CR26","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1097\/pas.0000000000001344","volume":"43","author":"B Esmaeli","year":"2019","unstructured":"Esmaeli B, Rubin ML, Xu S, Goepfert RP, Curry JL, Prieto VG, Ning J, Tetzlaff MT (2019) Greater tumor thickness, ulceration, and positive sentinel lymph node are associated with worse prognosis in patients with conjunctival melanoma: implications for future AJCC classifications. Am J Surg Pathol 43:1701\u20131710. https:\/\/doi.org\/10.1097\/pas.0000000000001344","journal-title":"Am J Surg Pathol"},{"key":"2830_CR27","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1001\/jamaophthalmol.2019.1656","volume":"137","author":"B Esmaeli","year":"2019","unstructured":"Esmaeli B (2019) Inclusion of histologic ulceration and tumor thickness in future American Joint Committee on Cancer T category definitions for conjunctival melanoma. JAMA Ophthalmol 137:912\u2013913. https:\/\/doi.org\/10.1001\/jamaophthalmol.2019.1656","journal-title":"JAMA Ophthalmol"},{"key":"2830_CR28","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1016\/j.ophtha.2020.07.031","volume":"127","author":"SK Freitag","year":"2020","unstructured":"Freitag SK, Aakalu VK, Tao JP, Wladis EJ, Foster JA, Sobel RK, Yen MT (2020) Sentinel lymph node biopsy for eyelid and conjunctival malignancy: a report by the American Academy of Ophthalmology. Ophthalmology 127:1757\u20131765. https:\/\/doi.org\/10.1016\/j.ophtha.2020.07.031","journal-title":"Ophthalmology"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-023-02830-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-023-02830-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-023-02830-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T07:12:07Z","timestamp":1695625927000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-023-02830-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,28]]},"references-count":28,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["2830"],"URL":"https:\/\/doi.org\/10.1007\/s10792-023-02830-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2817762\/v1","asserted-by":"object"}]},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,28]]},"assertion":[{"value":"14 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Ankara University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written and verbal infomed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed constent"}}]}}